Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Risk Stratification of Heart Failure in Cardiomyopathies.

Condition:   Cardiomyopathy With Unknown Etiology
Interventions:   Drug: etiologic treatment,anti-myocardial remodeling;   Drug: anti-myocardial remodeling;   Drug: anti-myocardial remodeling,anti-acute heart failure;   Drug: Etiological, anti-remodeling and symptom treatment
Sponsor:   RenJi Hospital
Not yet recruiting - verified October 2016

Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury

Sponsor:   Stanford University
Recruiting - verified October 2016

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Conditions:   Iron Deficiency;   Heart Failure
Interventions:   Drug: ferric carboxymaltose;   Other: Normal saline 0.9%
Sponsors:   Vifor Inc.;   Worldwide Clinical Trials;   Cytel Inc.
Not yet recruiting - verified September 2016

Catheter Ablation Versus Antiarrhythmic Drugs for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease

Conditions:   Heart Diseases;   Cardiomyopathies;   Ventricular Premature Complexes
Interventions:   Procedure: Procedure (Radiofrequency catheter ablation);   Drug: Antiarrhythmic Drug (Amiodarone, Flecainide/Propafenone)
Sponsors:   Heartcenter Leipzig GmbH;   Leipzig Heart Institute GmbH
Not yet recruiting - verified October 2016

A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Condition:   Cardiomyopathy, Hypertrophic Obstructive
Intervention:   Drug: MYK-461
Sponsor:   MyoKardia, Inc.
Recruiting - verified October 2016

Training-induced Increased Left Ventricular Trabeculation

Conditions:   Athletes Heart;   Left Ventricular Hypertrabeculation
Sponsors:   St George's, University of London;   St. Bartholomew's Hospital;   Cardiac Risk in the Young;   British Heart Foundation
Completed - verified October 2016

Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment

Condition:   Cardiomyopathies
Sponsors:   Duke University;   GE Healthcare
Active, not recruiting - verified September 2016

AVJ-514 Japan Trial

Conditions:   Mitral Stenosis With Insufficiency;   Functional Mitral Regurgitation;   Mitral Insufficiency;   Mitral Valve Incompetence;   Mitral Valve Regurgitation
Intervention:   Device: AVJ-514
Sponsor:   Abbott Vascular
Active, not recruiting - verified October 2016

Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae Contraction

Conditions:   Obesity;   Heart Failure
Intervention:   Other: functional tissu atrial analysis
Sponsor:   University Hospital, Lille
Recruiting - verified October 2016

Blended Collaborative Care for Heart Failure and Co-Morbid Depression

Conditions:   Heart Failure, Systolic;   Depression;   Cardiovascular Disease
Interventions:   Behavioral: Collaborative Care for Heart Failure;   Behavioral: Collaborative Care for Depression
Sponsors:   University of Pittsburgh;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2016

PHOspholamban RElated CArdiomyopathy STudy - Intervention

Condition:   Phospholamban R14del Mutation-related Cardiomyopathy
Intervention:   Drug: Eplerenone
Sponsors:   M.p. van den Berg, MD, PhD, professor in Cardiology;   Netherlands: TCC, Trial Coordination Center UMCG;   The Interuniversity Cardiology Institute of the Netherlands;   ZonMw: The Netherlands Organisation for Health Research and Development;   Netherlands: CVON, CardioVascular Research Netherlands
Recruiting - verified October 2016

Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY

Condition:   Hypertrophic Cardiomyopathy With Obstruction
Intervention:   Device: CRT-P Implant
Sponsor:   St. Jude Medical
Recruiting - verified October 2016

Fabry and Cardiomyopathy (FaCard) Epidemiological Study for the Analysis of Biomarkers and the Clinical Course of Patients With Fabry Disease and the N215S-mutation

Conditions:   Cerebrovascular Accident;   Stroke, Acute;   Cerebral Stroke
Sponsor:   University of Rostock
Recruiting - verified October 2016

PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)

Condition:   Non-ischemic Dilated Cardiomyopathy
Interventions:   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified October 2016

CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM

Condition:   Hypertrophic Obstructive Cardiomyopathy (HOCM)
Interventions:   Device: Biventricular pacing;   Device: No Pacing
Sponsor:   Hospital Clinic of Barcelona
Recruiting - verified October 2016

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Condition:   TTR-CM
Intervention:   Drug: tafamidis
Sponsor:   Pfizer
Active, not recruiting - verified October 2016